NASDAQ:ZSAN

Zosano Pharma SEC Filings & 10K Form

$0.90
+0.02 (+1.84 %)
(As of 04/23/2021 09:37 AM ET)
Add
Compare
Today's Range
$0.89
Now: $0.90
$0.90
50-Day Range
$0.77
MA: $1.19
$1.47
52-Week Range
$0.33
Now: $0.90
$3.06
Volume3,315 shs
Average Volume9.90 million shs
Market Capitalization$95.41 million
P/E RatioN/A
Dividend YieldN/A
Beta2.98

SEC Filings

Zosano Pharma (NASDAQ:ZSAN) SEC Filings

DateFilerForm TypeView
04/13/2021
3:33 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2021
8:33 PM
Lo Steven (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
8:33 PM
Lewis Hayley (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
8:31 PM
KELLERMAN DONALD J (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
8:30 PM
Matthews Christine (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2021
5:13 PM
Lo Steven (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2021
3:41 PM
Zosano Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2021
3:22 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2021
7:37 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2021
7:11 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2021
3:16 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
6:58 AM
SABBY MANAGEMENT, LLC (Filed by)
Zosano Pharma (Subject)
Form SC 13G/A
01/04/2021
3:15 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2020
3:10 PM
Zosano Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2020
3:08 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2020
7:45 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2020
4:24 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2020
4:21 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2020
4:22 PM
Zosano Pharma (Filer)
Form 424B5
08/31/2020
3:30 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2020
3:21 PM
Zosano Pharma (Filer)
Form 424B5
08/17/2020
3:20 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2020
3:12 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
8:01 AM
Zosano Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/29/2020
8:56 PM
Grais Linda S (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:47 PM
ELMS STEVE (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
7:26 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2020
3:33 PM
Zosano Pharma (Filer)
Form DEFA14A
06/08/2020
4:19 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2020
4:14 PM
Zosano Pharma (Filer)
Form 424B5
06/05/2020
5:43 PM
WALKER JOHN PETER (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:11 PM
Lo Steven (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:10 PM
ELMS STEVE (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
8:00 AM
Zosano Pharma (Filer)
Form DEF 14A
05/14/2020
4:27 PM
Zosano Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2020
4:06 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2020
11:15 PM
Zosano Pharma (Filer)
Form EFFECT
03/16/2020
3:21 PM
ARMISTICE CAPITAL, LLC (Filed by)
Zosano Pharma (Subject)
Form SC 13G
03/13/2020
8:52 PM
Zosano Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/06/2020
4:17 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2020
8:15 PM
Zosano Pharma (Filer)
Form 424B5
03/04/2020
4:27 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2020
4:25 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
11:01 AM
Flint Ridge Capital LLC (Filed by)
Zosano Pharma (Subject)
Form SC 13G/A
02/13/2020
3:17 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
12:58 PM
SABBY MANAGEMENT, LLC (Filed by)
Zosano Pharma (Subject)
Form SC 13G
01/08/2020
3:05 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
7:06 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
9:23 AM
Aisling Capital IV, LP (Reporting)
Aisling Capital Partners IV LLC (Reporting)
Aisling Capital Partners IV, LP (Reporting)
ELMS STEVE (Reporting)
SCHIFF ANDREW N (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
3:39 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2019
3:18 PM
Zosano Pharma (Filer)
Form 424B5
10/24/2019
8:04 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2019
3:28 PM
Lo Steven (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2019
3:26 PM
Lo Steven (Reporting)
Zosano Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2019
3:23 PM
Flint Ridge Capital LLC (Filed by)
Zosano Pharma (Subject)
Form SC 13G
10/10/2019
3:53 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
8:05 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
3:18 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2019
2:55 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
4:28 PM
Zosano Pharma (Filer)
Form 424B5
08/19/2019
4:28 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
4:24 PM
Zosano Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/22/2019
3:16 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2019
3:08 PM
Hagan Joseph P (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
3:07 PM
ELMS STEVE (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
3:07 PM
GREATHOUSE KENNETH (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
3:06 PM
XANTHOPOULOS KLEANTHIS G (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2019
3:06 PM
WILSON TROY EDWARD (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
3:34 PM
Zosano Pharma (Filer)
Form DEFA14A
06/19/2019
4:23 PM
Kitchener Gregory David (Reporting)
Zosano Pharma (Issuer)
Form 4/A
06/19/2019
4:22 PM
KELLERMAN DONALD J (Reporting)
Zosano Pharma (Issuer)
Form 4/A
06/19/2019
4:21 PM
Lewis Hayley (Reporting)
Zosano Pharma (Issuer)
Form 4/A
06/13/2019
3:07 PM
Kitchener Gregory David (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
4:28 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
3:48 PM
Zosano Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/18/2019
3:25 PM
WALKER JOHN PETER (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2019
3:15 PM
Aisling Capital IV, LP (Reporting)
Aisling Capital Partners IV LLC (Reporting)
Aisling Capital Partners IV, LP (Reporting)
ELMS STEVE (Reporting)
SCHIFF ANDREW N (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
4:02 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
3:24 PM
Zosano Pharma (Filer)
Form 424B5
04/08/2019
3:24 PM
Zosano Pharma (Filer)
Form 424B5
03/27/2019
11:15 PM
Zosano Pharma (Filer)
Form EFFECT
03/25/2019
7:59 AM
Zosano Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2019
3:10 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
4:09 PM
Zosano Pharma (Filer)
Form 8-K/A
01/16/2019
6:19 PM
Grais Linda S (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2019
6:17 PM
Grais Linda S (Reporting)
Zosano Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/16/2019
7:31 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
11:58 AM
SABBY MANAGEMENT, LLC (Filed by)
Zosano Pharma (Subject)
Form SC 13G/A
12/20/2018
8:49 AM
Zosano Pharma (Filer)
Form CT ORDER
11/15/2018
3:33 PM
Zosano Pharma (Filer)
Form NT 10-Q
11/15/2018
6:32 AM
Zosano Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/16/2018
3:54 PM
Kitchener Gregory David (Reporting)
Zosano Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2018
3:44 PM
Kitchener Gregory David (Reporting)
Zosano Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2018
7:32 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2018
7:32 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2018
7:32 AM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2018
3:33 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
4:17 PM
Zosano Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2018
3:08 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
3:28 PM
Zosano Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.